Frailty Score-guided Dosing of Lenalidomide, Dexamethasone and Daratumumab Induction Therapy in Elderly, Frail Newly Diagnosed Myeloma (MMY2035)
Latest Information Update: 13 Dec 2022
At a glance
- Drugs Daratumumab (Primary) ; Dexamethasone (Primary) ; Lenalidomide (Primary)
- Indications Multiple myeloma
- Focus Adverse reactions; Therapeutic Use
- Acronyms MMY2035
Most Recent Events
- 06 Dec 2022 Planned End Date changed from 31 Dec 2024 to 31 Dec 2023.
- 06 Dec 2022 Planned primary completion date changed from 31 Dec 2023 to 31 Dec 2022.
- 06 Dec 2022 Planned initiation date changed from 15 Dec 2021 to 6 Dec 2021.